MiR-133b |
Extraneous: lentiviral delivery |
Downregulate the expression of chondroitin sulfate proteoglycans, RhoA and inhibit microglia/macrophage proliferation (115) |
MiR-124 |
Extraneous: cell transfection |
Reduced proinflammatory molecules (116) |
MiR-873a-5p |
Endogenous: astrocyte-derived exosomes |
Reduce inflammatory cytokines, increase anti-inflammatory factors (117) |
MiR-34a |
Extraneous: intrathecal injection |
Reduce inflammatory cytokines secretion of microglia, promote neural recovery and locomotor function (118) |
MiR-150 |
Extraneous: cell transfection |
Decrease the expression of pro-inflammatory cytokines (119) |
MiR-216a-5p |
Endogenous: MSC-derived exosomes |
Switching microglial phenotype to secret anti-inflammatory molecules (111) |
MiR-340-5p |
Extraneous: cell transfection |
Attenuate inflammation, oxidative stress, and apoptosis (120) |
MiR-23b |
Extraneous: cell transfection |
Inhibited the BV-2 cells apoptosis and NF-κB activation (121) |
MiR-193a antagomir |
Extraneous: cell transfection |
Reduced expression of neuroinflammatory molecules (122) |
miR-429 inhibitors |
Extraneous: cell transfection |
Reduced expression of neuroinflammatory molecules (123) |
MiR-223-5p inhibitor |
Extraneous: intrathecal injection |
Reduced expression of neuroinflammatory molecules, reduced neuron apoptosis and promoted locomotor recovery (124) |
MiR27a |
Extraneous: cell transfection |
Alleviate apoptosis and inflammatory injury (125) |
MiR100 |
Extraneous: cell transfection and intrathecal injection |
Suppresses microglia activation and neuronal apoptosis (126) |
MiR-183 |
Extraneous: intracerebroventrivular injection |
Inhibits microglia activation and expression of inflammatory factors (127) |